1 active not recruiting, 1 completed. 1 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Active not recruiting 1 |
| Phase 3 | 1 | Completed 1 |
Follow Aripiprazole 5mg: new trials by email Literature Review of Aripiprazole 5mg trials Research Report on Aripiprazole 5mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Neurobiological Mechanisms of Pathological Rumination and Effects of Aripiprazole Escitalopram, Aripiprazole 5mg - Major Depressive Disorder (MDD), Rumination | Not applicable | Active not recruiting | Central South University | 108 | 2025-05-08 | 2026-06-12 |
| A Double-Blind, Placebo-Controlled Study of Aripiprazole Adjunctive to Antidepressant Therapy Aripiprazole 5mg, Aripiprazole 2mg, Placebo - Major Depressive Disorder | Phase 3 | Completed | Massachusetts General Hospital | 225 | 2008-09-01 | 2017-07-19 |
Depressive Disorder, Major (2) · Depression (1) · Neurobehavioral Manifestations (1) · Rumination Syndrome (1)
Central South University (1) · Massachusetts General Hospital (1)
China (1) · United States (1)
Maurizio Fava, MD (1) · Yan Zhang (1)